Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Treleaven

Showing results (41-50 of 164) with videos related to

Pageof 17
Sort By:
Bone Marrow Transplantation|December 1, 1995
Allogeneic bone marrow transplantation for primary myelofibrosisS Singhal, R Powles, J Treleaven, et al.
Bone Marrow Transplantation|May 25, 1999
Long-term outcome of adult acute leukemia patients who are alive and well 2 years after autologous blood or marrow transplantationS Singhal, R Powles, J Treleaven, et al.
Bone Marrow Transplantation|June 1, 1995
Relationship between donor-recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblingsJ Mehta, R Powles, C Horton, et al.
Leukemia & Lymphoma|July 1, 1993
Arsenic and AyurvedaJ Treleaven, S Meller, P Farmer, et al.
Leukemia & Lymphoma|August 10, 1999
Long-term outcome of adult acute leukemia patients who are alive and well two years after allogeneic bone marrow transplantation from an HLA-identical siblingS Singhal, R Powles, J Treleaven, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1995
Listeriosis in bone marrow transplant recipients: incidence, clinical features, and treatmentJ Chang, R Powles, J Mehta, et al.
Bone Marrow Transplantation|April 13, 2004
High-dose melphalan and autotransplantation followed by post transplant maintenance chemotherapy for acute lymphoblastic leukemia in first remissionJ Mehta, R Powles, B Sirohi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2003
Risk factors for increased variability in dialysis delivery in haemodialysis patientsK Scott Brimble, Darin J Treleaven, Joye St Onge, et al.
Blood|May 23, 1998
Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantationR Powles, S Singhal, J Treleaven, et al.
Bone Marrow Transplantation|November 7, 2002
Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myelomaS Singhal, R Powles, B Sirohi, et al.
Pageof 17

Showing results (41-50 of 164) with videos related to

Sort By:
Pageof 17
Bone Marrow Transplantation|December 1, 1995
Allogeneic bone marrow transplantation for primary myelofibrosisS Singhal, R Powles, J Treleaven, et al.
Bone Marrow Transplantation|May 25, 1999
Long-term outcome of adult acute leukemia patients who are alive and well 2 years after autologous blood or marrow transplantationS Singhal, R Powles, J Treleaven, et al.
Bone Marrow Transplantation|June 1, 1995
Relationship between donor-recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblingsJ Mehta, R Powles, C Horton, et al.
Leukemia & Lymphoma|July 1, 1993
Arsenic and AyurvedaJ Treleaven, S Meller, P Farmer, et al.
Leukemia & Lymphoma|August 10, 1999
Long-term outcome of adult acute leukemia patients who are alive and well two years after allogeneic bone marrow transplantation from an HLA-identical siblingS Singhal, R Powles, J Treleaven, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1995
Listeriosis in bone marrow transplant recipients: incidence, clinical features, and treatmentJ Chang, R Powles, J Mehta, et al.
Bone Marrow Transplantation|April 13, 2004
High-dose melphalan and autotransplantation followed by post transplant maintenance chemotherapy for acute lymphoblastic leukemia in first remissionJ Mehta, R Powles, B Sirohi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2003
Risk factors for increased variability in dialysis delivery in haemodialysis patientsK Scott Brimble, Darin J Treleaven, Joye St Onge, et al.
Blood|May 23, 1998
Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantationR Powles, S Singhal, J Treleaven, et al.
Bone Marrow Transplantation|November 7, 2002
Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myelomaS Singhal, R Powles, B Sirohi, et al.
Pageof 17